GT
AZN icon

Glenview Trust’s AstraZeneca AZN Stock Holding History

Glenview Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$824K Buy
4,346
+396
+10% +$74.5K 0.01% 320
2026
Q1 		$779K Sell
3,950
-12
-0.3% -$2.31K 0.01% 320
2025
Q4 		$728K Buy
3,962
+1,565
+65% +$274K 0.01% 320
2025
Q3 		$368K Sell
2,397
-157
-6% -$23.8K 0.01% 405
2025
Q2 		$357K Buy
2,554
+383
+18% +$53.7K 0.01% 406
2025
Q1 		$319K Sell
2,171
-36
-2% -$5.21K 0.01% 404
2024
Q4 		$289K Sell
2,207
-8
-0.4% -$1.12K 0.01% 420
2024
Q3 		$345K Sell
2,215
-611
-22% -$98.6K 0.01% 398
2024
Q2 		$441K Buy
2,826
+498
+21% +$74.9K 0.01% 368
2024
Q1 		$315K Sell
2,328
-61
-3% -$8.08K 0.01% 391
2023
Q4 		$322K Buy
2,389
+27
+1% +$3.51K 0.01% 392
2023
Q3 		$320K Buy
2,362
+87
+4% +$11.9K 0.01% 370
2023
Q2 		$326K Buy
2,275
+86
+4% +$12.7K 0.01% 374
2023
Q1 		$304K Hold
2,189
– – 0.01% 374
2022
Q4 		$297K Buy
2,189
+110
+5% +$13.8K 0.01% 368
2022
Q3 		$228K Buy
+2,079
New +$264K 0.01% 381
2021
Q4 		– Sell
-3,086
Closed -$371K – 416
2021
Q3 		$371K Buy
+3,086
New +$359K 0.01% 313
2013
Q4 		$358K Buy
+6,024
New +$327K 0.04% 164

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Glenview Trust's AZN Position: Q2 2026 in Review

Glenview Trust increased its AstraZeneca (AZN) stake by 10% in Q2 2026, buying an estimated $74.5K and bringing the position to 4,346 shares worth $824K. The position accounts for 0.01% of the portfolio, ranked #320.

Glenview Trust first reported a position in AZN in Q4 2013 and has held it in 18 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Glenview Trust held 4,346 shares of AstraZeneca worth $824K as of Q2 2026.
  • Glenview Trust bought 396 AstraZeneca shares in Q2 2026, an estimated $74.5K.
  • AstraZeneca made up 0.01% of Glenview Trust's portfolio in Q2 2026, its #320 holding.
  • Glenview Trust first reported a position in AstraZeneca in Q4 2013 and has held it in 18 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.